Novo says Wegovy lowers BMI in children in trial
Novo Nordisk said Wegovy lowered BMI and obesity rates in children in a trial.
Why it matters
Possible first drug for under-12s.
Background
Approved from age 12.
The story so far
- Wegovy lowers BMI in children in trial
- Novo says Wegovy lowers BMI in children in trial
Sources
- CNBC ↗Nov 16, 10:00 AM ET
This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.